Methylprednisolone Completed Phase 2 Trials for Graft Versus Host Disease (GVHD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02176031Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD
NCT00609609Photopheresis for the Treatment of Acute Graft Versus Host Disease